S&P Global (NYSE: SPGI) today announced an agreement with a group led by majority investor Motive Partners, a private ...
New safety and pharmacokinetic data from Phase 3 C-POST trial provide insights on an every 6-week dosing regimen of adjuvant Libtayo® (cemiplimab) in high-risk cutaneous squamous cell ...
Connections: Sports Edition is a New York Times word game about finding common sports threads between words. How to solve the ...
Abstract: Dynamic environments pose great challenges for expensive optimization problems, as the objective functions of these problems change over time and thus require remarkable computational ...